Yahoo! News Reports on the NuvaRing® Multi-District Litigation
On April 26, 2013, Yahoo! News released an article regarding the NuvaRing® Multi-District Litigation (MDL) currently pending in the Eastern District of Missouri. In particular, the article reported that more than 1,000 women are suing the manufacturers of NuvaRing® alleging that NuvaRing® caused them to suffer serious – and sometimes fatal – blood clots. Plaintiffs also allege that they were inadequately warned by the company of the increased risk of blood clots associated with NuvaRing®.
One of these women is Rachel Payne, who was only 20 years old when she suffered a life-threatening pulmonary embolism. One minute she was eating lunch with her father and the next minute she found herself spatting up large chunks of blood on the sidewalk. She was hospitalized for 10 days in order to save her life. Her doctors could not figure out how this could happen to an otherwise healthy, young woman – until they found out she was using NuvaRing®.
NuvaRing® is a combined hormonal contraceptive vaginal ring that contains ethinyl estradiol (EE), an estrogen, and etonogestrel (ENG), a third generation progestin. Since the early 1990s, several scientific studies have been published indicating that hormonal contraceptives containing third generation progestins, such as NuvaRing®, are associated with an increased risk of blood clots in comparison to hormonal contraceptives containing second generation progestins.
The first trial in the NuvaRing® Multi-District Litigation is currently set to begin in October 2013.
The Yahoo! News article can be found here.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements.